Αποτελέσματα Αναζήτησης
In this review, we provide an overview on currently available anti-HIV drugs and the latest developments in antiretroviral therapy, focused on new antiretroviral agents acting on known and unexploited antiviral targets, prevention therapies aimed to improve available drug combinations, and research on new long-acting therapies, particularly ...
5 Αυγ 2022 · Cabotegravir is the latest WHO-recommended drug that protects against HIV infection. In January 2021, the agency approved the use of a vaginal ring coated with the anti-HIV drug dapivirine.
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
22 Ιουλ 2022 · Infrequently dosed, longer-acting antiretroviral agents are making adherence to medication easier, leading to better outcomes for those living with HIV or at risk of infection.
21 Ιουν 2023 · The new generation of long-acting or extended-release antiretroviral drugs, including long-acting broadly neutralizing monoclonal antibodies, has great promise for advancing biomedical HIV ...
9 Σεπ 2021 · Current oral triple-drug treatments of HIV infection combine a potent HIV integrase strand transfer inhibitor (INSTI) (e.g. dolutegravir, bictegravir) or an NNRTI (e.g. rilpivirine, doravirine, etravirine) plus two NRTIs (e.g. tenofovir, emtricitabine, lamivudine).
11 Δεκ 2023 · Using drug therapy to block transmission and prevent HIV, HIV pre-exposure prophylaxis (PrEP) provides a critical intervention to reduce community spread and protect those with reasons to utilize PrEP.
